BETTUZZI, Saverio
 Distribuzione geografica
Continente #
NA - Nord America 7.723
AS - Asia 6.447
EU - Europa 5.076
SA - Sud America 1.155
AF - Africa 336
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 15
Totale 20.767
Nazione #
US - Stati Uniti d'America 7.488
SG - Singapore 2.640
CN - Cina 2.146
IE - Irlanda 962
BR - Brasile 900
UA - Ucraina 750
FI - Finlandia 658
SE - Svezia 642
IT - Italia 639
DE - Germania 531
HK - Hong Kong 502
VN - Vietnam 496
NL - Olanda 243
ZA - Sudafrica 229
CA - Canada 186
TR - Turchia 155
AT - Austria 138
FR - Francia 125
GB - Regno Unito 123
AR - Argentina 104
RU - Federazione Russa 99
IN - India 96
BD - Bangladesh 87
IR - Iran 70
KR - Corea 65
EC - Ecuador 48
BE - Belgio 38
CI - Costa d'Avorio 33
ID - Indonesia 31
IQ - Iraq 30
MX - Messico 29
JP - Giappone 27
VE - Venezuela 26
CO - Colombia 24
PL - Polonia 24
ES - Italia 19
UZ - Uzbekistan 19
MA - Marocco 18
CZ - Repubblica Ceca 17
EG - Egitto 15
PY - Paraguay 14
CL - Cile 13
EU - Europa 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
KE - Kenya 11
LT - Lituania 11
SK - Slovacchia (Repubblica Slovacca) 11
TN - Tunisia 10
UY - Uruguay 10
IL - Israele 8
NP - Nepal 8
AZ - Azerbaigian 7
PK - Pakistan 7
RO - Romania 7
BG - Bulgaria 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
JO - Giordania 5
SA - Arabia Saudita 5
BO - Bolivia 4
DZ - Algeria 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AL - Albania 3
CR - Costa Rica 3
DK - Danimarca 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
OM - Oman 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
BI - Burundi 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MR - Mauritania 2
MY - Malesia 2
NG - Nigeria 2
PH - Filippine 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
LY - Libia 1
Totale 20.757
Città #
Singapore 1.153
Dublin 961
Jacksonville 867
Ashburn 857
Chandler 833
Dearborn 509
Hong Kong 501
Santa Clara 484
Beijing 475
Boardman 279
Nanjing 272
Dallas 251
Ann Arbor 248
San Mateo 224
Johannesburg 215
Princeton 211
Ho Chi Minh City 174
Parma 170
Toronto 135
Shanghai 127
Vienna 124
Los Angeles 121
Wilmington 116
Hefei 113
Izmir 113
Nanchang 96
Shenyang 96
Hanoi 89
São Paulo 83
Jinan 81
Munich 81
Helsinki 77
Hebei 73
Moscow 68
Leawood 67
New York 67
Des Moines 64
Kunming 61
Seoul 60
Tianjin 59
Changsha 56
Guangzhou 51
Jiaxing 49
Buffalo 45
Marseille 41
Columbus 38
Houston 38
Augusta 37
Brussels 37
Turku 36
Seattle 34
Abidjan 33
Council Bluffs 32
Milan 32
Fremont 31
Ardabil 30
Haikou 30
The Dalles 30
Woodbridge 29
Brooklyn 28
Rio de Janeiro 27
Rome 25
Tokyo 25
Zhengzhou 25
London 24
Haiphong 23
Kocaeli 23
Chicago 22
Nuremberg 22
Da Nang 21
Norwalk 21
Warsaw 21
Ardea 20
Biên Hòa 20
Montreal 20
Hangzhou 19
Monmouth Junction 19
Belo Horizonte 18
Curitiba 18
Mumbai 18
Tashkent 18
Bologna 17
Quito 17
Stockholm 17
Denver 16
Redondo Beach 16
Taiyuan 16
Chengdu 15
Falls Church 15
Grafing 15
Modena 15
Ninh Bình 15
Porto Alegre 15
Atlanta 14
Chennai 14
Dong Ket 14
Phoenix 14
San Jose 14
Guayaquil 13
Hải Dương 13
Totale 12.126
Nome #
Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development 438
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 244
Flavonoids as epigenetic modulators for prostate cancer prevention 226
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 210
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 197
ATTIVITÀ CHEMIO PREVENTIVA DELLE CATECHINE DEL TÈ VERDE NEL CANCRO DELLA PROSTATA 194
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 180
The down-regulation of clusterin expression enhances the αsynuclein aggregation process 172
Lemur tyrosine kinases and prostate cancer: A literature review 172
A novel transgenic model for prostate cancer displays the tumor-suppressor activity of Clusterin 170
AA Sequencing, Glycosylation and Phosphorylation Site Characterization of Human Serum Clusterin using Liquid Chromatography-High Resolution Mass Spectrometry 167
Acute hyperbaric oxygen (HBO) treatment rapidly upregulate ODC and downregulate SSAT in the rat heart, boosting polyamine tissue concentration: evidence for a protective role of natural polyamines in heart failure as naturally occurring in vivo antioxidants? 165
Epigenetic regulation of clusterin transcriptional variants in normal, immortalized and cancerous human cell lines 162
CLU expression negatively modulates prostate cancer progression by inhibiting NF-kB activity 161
Clusterin 161
Rat cardiac polyamine metabolism response to HBO (hyperbaric oxygen)depends on intensity of treatment 158
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 157
The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review 155
Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells 154
Apoptosi: ruolo fisiologico della morte cellulare 152
Changes in prostate polyamine metabolism by green tea catechins in autochtonous mouse model of prostate cancer (TRAMP mice) 149
Chronic administration of green tea extract to TRAMP mice induces the collapse ofGolgi apparatus in prostate secretory cells and results in alterations of proteinpost-translational processing. 147
MOLECULAR MECHANISM OF ACTION OF POLYPHENON E, A GREEN TEA EXTRACT, IN BENIGN AND TUMORIGENIC PROSTATE EPITHELIAL CELLS 146
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 146
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 144
Age-dependent expression of sulphated glycoprotein-2 (SGP-2) transcript in the ventral prostate of rats 141
Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis 141
Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study 138
Green tea catechins for prostate cancer prevention: Present achievements and future challenges 138
Effects of CLU over-expression on NF-kB target genes involved in invasion mechanims: preliminary results 137
Changes in rat SOD activity localization following HBO treatment 136
Upregulation of Clusterin in Prostate and DNA Damage in Spermatozoa from Bisphenol A-Treated Rats, and Formation of DNA Adducts in Cultured Human Prostatic Cells 135
Protezione del miocardio ischemico: protezione del miocardio mediante attivita' fisica ed ossigeno iperbarico; valutazione dello stress metabolico, del quadro ossidativo e ormonale 134
Effects of Clusterin knock down on prostate cancer progression in the tramp model 133
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 133
Clinical relevance of green tea catechins on prostate cancer progression in “high risk” men in combination with molecular profiling of catechin-resistant tumors” 132
Roles of Autophagy Induced by Natural Compounds in Prostate Cancer 132
Clusterin as possible biomarker of response to treatment of prostate cancer cells with Polyphenon E 132
A New transgenic model for prostate cancer and the role of CLU in tumorigenesis 131
CLUSTERIN IS EPIGENETICALLY REPRESSED IN HUMAN PROSTATE CANCER CELLS 131
The role of clusterin on alpha-synuclein aggregation in an “in vitro” model of Parkinson disease 131
B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: Implications for cell survival 130
Molecular targets of (-)-Epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts 130
Chemoprevention of human prostate cancer by green tea catechins: two years later, a follow-up update 129
Aspects of protein biosynthesis in hypertrophic growth of rat heart 128
Clusterin is epigenetically repressed in human prostate cancer cells 128
Chemoprevention of human prostate cancer (PCa) by oral administration of green tea catechins (GTCs) in high grade pin (HGPIN) subjects: a preliminary report from a 1 year proof of principle study 125
Chronic Administration of Green Tea Extracts in TRAMP Mice Reduces the Activity of the Secretory Pathway Causing an Imbalance of the Protein Trafficking 125
EGCG antagonizes Bortezomib-, but not MG132-induced cell death in prostate cancer cells 125
Deciphering the role of the molecular chaperone clusterin on α-synuclein aggregation. 125
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins (GTCs) in High Grade PIN Volunteers: a Preliminary Report from a 1 Year Proof-of-Principle Study 123
Ca2+ depletion caused nuclear translocation of a 45kda death-isoform of clusterin and anoikis induction in prostate cells 121
A new transgenic model for prostate cancer (TRAMP/CluKO) and the role of CLU in tumorigenesis 121
Anti-tumor activity of Green Tea Catechins against human prostate cancer: the clinical trial 120
Apoptotic activity and levels of SGP-2 (clusterin) mRNA in the ventral prostate of the aging ra 120
Clusterin (CLU): From one gene and two transcripts to many proteins 118
Clusterin (CLU) and prostate cancer 118
Chemoprevention of human prostate cancer by oral administration of green tea catechins 118
Le catechine estratte dal tè verde per la prevenzione del tumore della prostata 117
Anticancer activity of green tea polyphenols in prostate gland 116
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 116
N-Myc-mediated epigenetic reprogramming in advanced prostate cancer: personalized medicine and quality of biological samples 115
Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kda nuclear isoform of clusterin 113
Clusterin gene expression as a novel biomarker of response to chemoprevention with GTE in humans 113
Androgen responsiveness and intrarenal localization of transcripts coding for the enzymes of polyamine metabolism in the mouse 112
Clusterin (CLU) and lung cancer 112
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 112
Influence of hyperbaric oxygen (HBO) on rat cardiac polyamine metabolism. 111
Clinical relevance of the inhibitory effect of Green Tea Catechins (GTCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view 111
Determination of the level of expression of ODC, AdoMetDC, OAZ and SSAT for molecular classification of Green Tea Catechins-sensitive and –resistant Prostate Cancer in the TRAMP mice model by q-PCR gene profiling 111
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 105
Clusterin is epigenetically repressed in human prostate cancer. 103
Anti-tumor activity of polyphenols against prostate cancer 103
Editorial: Challenges in the prevention of prostate cancer 99
Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5 years follow-up study 99
Identification of an androgen-repressed mRNA in rat ventral prostate as coding for Sulphated Glycoprotein 2 by cDNA cloning and sequence analysis 99
Variazioni del profilo e della funzionalità polisomale di branzino (Dicentrarchus labrax) in condizioni di ridotto accrescimento 97
Identification and characterization of a novel promoter of the CLU gene which drives the expression of a rare CLU mRNA variant in PCa cells following administration of epigenetic drugs. 97
Clusterin (SGP-2) gene expression is cell cycle dependent in normal human dermal fibroblasts 96
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 96
The tumor-suppressor activity of Clusterin (CLU) is fully displayed in a novel transgenic model for prostate cancer: the TRAMP/CluKO mice model 96
The new anti-oncogene clusterin and the molecular profiling of prostate cancer progression and prognosis 95
Increased levels of clusterin mRNA in the ventral prostate of the aging rat are associated to increases in cuboidal (atrophic) cell population and not to changes in apoptotic activity 95
Clusterin (SGP-2) transient overexpression decreases proliferation rate of sv40-immortalised human prostate epithelial cells by slowing down cell cycle progression 95
Green tea catechins for chemoprevention of human prostate cancer: from the bench (basic research) to the bedside (result of the clinical trial) 94
Clusterin Mediated Apoptosis is Regulated by APC and is P21 Dependent but P53 Independent 93
Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts 93
Inhibitory Effects of Green Tea Catechins on Prostate Cancer progression 93
Human Prostate Cancer Prevention by Green Tea Catechins:Clinical Trial and Putative Molecular Mechanism of Action 93
Regional increases in ornithine decarboxylase mRNA levels in the rat brain after partial mesodiencephalic hemitransection as revealed by in situ hybridization histochemistry 93
Studies on the relationship between cell proliferation and cell death: apposite patterns of SGP-2 and ornithine decarboxylase mRNA accumulation in PHA-stimulated human limphocytes 91
SGP-2, apoptosis and aging 91
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 91
Inhibition of spontaneous and androgen-induced prostate growth by a non hypercalcemic calcitriol analogue 90
Development of a green fluorescent reporter for the bio-assay of anti-cancer drugs with anti-oxidant activity 90
Il tè verde nella chemoprevenzione oncologica 90
Role of Clusterin in normal or tumoral bronchial human cells exposed to cigarette smoke 89
The Clusterin Paradigm in Prostate and Breast Carcinogenesis 89
Clusterin: an “enigmatic” protein that turns to a novel tumour-suppressor gene 88
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer 88
Totale 12.976
Categoria #
all - tutte 72.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.144 0 0 0 0 0 57 212 45 303 51 449 27
2021/20221.143 22 60 8 29 43 30 153 172 57 100 146 323
2022/20233.236 377 290 228 263 232 363 22 196 1.125 9 95 36
2023/20241.097 88 99 44 27 166 251 66 55 24 44 85 148
2024/20254.160 82 265 269 208 374 410 105 111 572 524 498 742
2025/20265.091 760 897 915 967 1.194 358 0 0 0 0 0 0
Totale 20.884